These findings emphasize that although we find that AR inhibition strongly inhibited ER+ BC OXPHOS in vitro, the effect in vivo remains to be evaluated particularly with long-term follow-up and may be restricted to a subpopulation identified through further investigation. Here, AR is linked to breast cancer.